載入...
Transarterial injection of recombinant human type-5 adenovirus H101 in combination with transarterial chemoembolization (TACE) improves overall and progressive-free survival in unresectable hepatocellular carcinoma (HCC)
BACKGROUND: The aim of this study was to determine the clinical benefit of transhepatic arterial chemoembolization (TACE) with or without recombinant human adenovirus type 5 (H101) administration for the treatment of patients with hepatocellular carcinoma (HCC). METHODS: Tumor response, progression-...
Na minha lista:
| 發表在: | BMC Cancer |
|---|---|
| Main Authors: | , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BioMed Central
2015
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4608280/ https://ncbi.nlm.nih.gov/pubmed/26470869 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-015-1715-x |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|